FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...

AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Inclusive leadership is demonstrated through consistent respect, psychological safety, and communication that makes patients ...

After four ovarian cancer recurrences, one survivor reflects on resilience, gratitude, and the life lessons that transformed her cancer journey.

Oncology physical therapist Dr. Leslie Waltke demonstrates calf raises, a simple at-home exercise to help rebuild lower body ...

Serving as nurse director, she integrates advanced prostate cancer therapeutics knowledge, triage, and counseling, earning physician reliance and strong patient trust during high-anxiety visits.

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...

Her proposal to quantify ropeginterferon alfa-2b transport during pregnancy catalyzed cross-disciplinary collaboration and ...

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

The discussion concludes with examination of recent research developments, particularly the CROWN trial's 7-year follow-up data presented at the American Society of Clinical Oncology meeting. Dr.